Download PDF
Thromb Haemost 1995; 74(01): 139-148
DOI: 10.1055/s-0038-1642667
Plenary Lecture
Schattauer GmbH Stuttgart

New Molecular Insights into the Genetics of Thrombophilia. Resistance to Activated Protein C Caused by Arg506 to Gin Mutation in Factor V as a Pathogenic Risk Factor for Venous Thrombosis

Björn Dahlbäck
Department of Clinical Chemistry and Coagulation Research, University of Lund, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Goldhaber SZ. TEpidemiology of pulmonary embolism and deep vein thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenhamn EG D. eds. Haemostasis and Thrombosis. 3rd. ed. Churchill Livinstone: 1994: 1327-1333
    Google Scholar
  • 2 Thomas DP. TPathogenesis of venous thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. eds. Haemostasis and Thrombosis. 3rd. ed. Churchill Livingstone: 1994: 1335-1347
    Google Scholar
  • 3 Allaart CF, Briët E. Familial venous thrombophilia. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. eds. Haemostasis and Thrombosis. 3rd. ed. Churchill Livingstone: 1994: 1349-1360
    Google Scholar
  • 4 Dahlbä ck, Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease -critical evaluation of laboratory investigation. Thromb Haemost 1992; 68: 7-13
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Heijboer H, Brandjes D, Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516
    CrossrefPubMedGoogle Scholar
  • 6 Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposion to thrombosis. Cell 1993; 72: 477-480
    CrossrefPubMedGoogle Scholar
  • 7 Tabemero MD, Tomas IF, Alberca I, Orfao A, Borrasca AL, Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 1991; 36: 249-254
    CrossrefPubMedGoogle Scholar
  • 8 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 9 Bertina RM, Koeleman BP C, Koster T, Rosendaal FR, Dirven RH, de Reside H, vanderVelden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 10 Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1362-1363
    PubMedGoogle Scholar
  • 11 Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-1538
    CrossrefPubMedGoogle Scholar
  • 12 Voorberg J, Roelse J, Koopman R, Büller H, Berends F, ten Cate JT, Mertens K, vanMourik JA. Association of idiopathicthromboembolism with single point mutation at Arg506 of factor V. Lancet 1994; 343: 1535-1536
    CrossrefPubMedGoogle Scholar
  • 13 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-521
    CrossrefPubMedGoogle Scholar
  • 14 Koster T, Rosendaal FR, de Ronde F, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 15 Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintainance, and regulation. Biochemistry 1991; 30: 10363-10370
    CrossrefPubMedGoogle Scholar
  • 16 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8
    PubMedGoogle Scholar
  • 17 Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988; 53: 505-518
    CrossrefPubMedGoogle Scholar
  • 18 Kane WH, Davie EW. Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and trombotic disorders. Blood 1988; 71: 539-555
    PubMedGoogle Scholar
  • 19 Jenny RJ, Tracy PB, Mann KG. The physiology and Biochemistry of factor V. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. eds. Haemostasis and Thrombosis. 3rd. ed. Churchill Livingstone: 1994: 465-476
    Google Scholar
  • 20 Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 1993; 70: 29-35
    PubMedGoogle Scholar
  • 21 Esmon CT. Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 1993; 9: 1-26
    CrossrefPubMedGoogle Scholar
  • 22 Dahlbäck B. Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Esmon CT. The Protein C Anticoagulant Pathway. Arterioscler Thromb 1992; 12: 135-145
    CrossrefPubMedGoogle Scholar
  • 24 Dahlbäck B, Stenflo J. The protein C anticoagulant system. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H. eds. The molecular basis of blood diseases. Philadelphia: W: Saunders B. 1994: 599-628
    Google Scholar
  • 25 Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-2567
    CrossrefPubMedGoogle Scholar
  • 26 Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor Villa. J Biol Chem 1994; 269: 18735-18738
    PubMedGoogle Scholar
  • 27 Marlar RA, Kressin DC, Madden RM. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma. Thromb Haemost 1993; 69: 16-20
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Fay PJ. Factor VIII structure and function. Thromb Haemost 1993; 70: 63-67
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Kalifatis M, Mann KG. Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem 1993; 268: 27246-27257
    PubMedGoogle Scholar
  • 30 Odegaard B, Mann KG. Proteolysis of factor Vaby factor Xa and activated protein C. J Biol Chem 1987; 262: 11233-11238
    PubMedGoogle Scholar
  • 31 Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation ofhuman factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-31880
    PubMedGoogle Scholar
  • 32 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746
    PubMedGoogle Scholar
  • 33 Stenflo J. A new vitamin K-dependent protein. J Biol Chem 1976; 251: 355-363
    PubMedGoogle Scholar
  • 34 Kisiel W, Canfield WM, Ericsson LH, Davie EW. `Anticoagulant properties of bovine plasma protein C following activation by thrombin. J Biol Chem 1977; 16: 5824-5831
    PubMedGoogle Scholar
  • 35 He X, Shen L, Bjartell A, Malm J, Lilja H, Dahlbäck B. The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues. J Histochem Cytochem. 1995 (in press)
    PubMedGoogle Scholar
  • 36 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
    CrossrefPubMedGoogle Scholar
  • 37 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor forthrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
    PubMedGoogle Scholar
  • 38 Walker FJ. Regulation of activated protein Cby a new protein. J Biol Chem 1980; 255: 5521-5524
    PubMedGoogle Scholar
  • 39 Walker FJ. Regulation of activated protein C by protein S, the role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-11131
    PubMedGoogle Scholar
  • 40 Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877
    PubMedGoogle Scholar
  • 41 Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Nad Acad Sci USA 1994; 91: 2728-2732
    CrossrefPubMedGoogle Scholar
  • 42 Hackeng TM, van’t Veer C, Meijers JC M, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions withfactors Va and Xa. J Biol Chem 1994; 269: 21051-21058
    PubMedGoogle Scholar
  • 43 Dahlbäck B, Lundwall Å, Stenflo J. Primary structure of bovine vitamin Independent protein S. Proc Natl Acad Sci USA.
    PubMedGoogle Scholar
  • 44 Discipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX, factor X, and protein S. Biochemisty 1977; 16: 698-706
    CrossrefPubMedGoogle Scholar
  • 45 Dahlbäck B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 1981; 78: 2512-2516
    CrossrefPubMedGoogle Scholar
  • 46 Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-846
    CrossrefPubMedGoogle Scholar
  • 47 Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 1983; 209: 847-856
    CrossrefPubMedGoogle Scholar
  • 48 Dahlbäck B. Inhibition of protein Ca cofactor function ofhuman and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-12027
    PubMedGoogle Scholar
  • 49 Beitina RM, van Wijngaarden A, Reinalda-Poot J, Poort SR, Bom VJ. Determination of plasma protein S - the protein cofactor of activated protein C. Thromb Haemost 1985; 53: 268-272
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088
    CrossrefPubMedGoogle Scholar
  • 51 Suzuki K, Nishioka J, Matsuda J, Maruyama I, Hashimoto S. Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va. J Biochem 1984; 96: 455-460
    CrossrefPubMedGoogle Scholar
  • 52 Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985; 260: 2007-2010
    PubMedGoogle Scholar
  • 53 Stem DM, Nawroth PP, Harris KW, Esmon CT. Cultured bovine aortic endothelial cells promote activated protein C - protein S-mediated inactivation of factor Va. J Biol Chem 1986; 261: 713-718
    PubMedGoogle Scholar
  • 54 Nelsestuen GL, Kisiel W, Discipio RG. Interaction of vitamin K dependent proteins with membranes. Biochemistry 1978; 17: 2134-2138
    CrossrefPubMedGoogle Scholar
  • 55 Dahlbäck B, Wiedmer T, Sims PJ. Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochemisty 1992; 31: 12769-12777
    CrossrefPubMedGoogle Scholar
  • 56 Bakker H, Tans G, Janssen-Claessen T, Thomassen MC L G D, Hemker HC, Griffin JH, Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 1992; 208: 171-178
    CrossrefPubMedGoogle Scholar
  • 57 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor V by activated protein C. J Biol Chem 1988; 263: 14884-14890
    PubMedGoogle Scholar
  • 58 Regan LM, Lamphear BJ, Walker FJ, Fay PJ. Factor IXa protects factor Villa from activated protein C: Factor IXa inhibits activated protein C- catalyzed cleavage of factor VIIIa at Arg562 . J Biol Chem 1994; 269: 9445-9452
    PubMedGoogle Scholar
  • 59 Salem HH, Esmon NL, Esmon CT, Majerus PW. Effects ofthrombomodulin and coagulation factor Va-light chain on protein C activation in vitro. J Clin Invest 1984; 73: 968-972
    CrossrefPubMedGoogle Scholar
  • 60 Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988; 59: 18-22
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Reitsma PH, Poort SR, Bemardi F, Gandrille S, Long GL, Sala N, Cooper DN. Protein C deficiency: a database of mutations. Thromb Haemost 1993; 69: 77-84
    Article in Thieme ConnectPubMedGoogle Scholar
  • 62 Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 1990; 16: 299-309
    Article in Thieme ConnectPubMedGoogle Scholar
  • 63 Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchemia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with purified protein C concentrate. N Engl J Med 1991; 325: 1565-1568
    CrossrefPubMedGoogle Scholar
  • 64 Bovill EG, Bauer KA, Dickermann JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712-717
    PubMedGoogle Scholar
  • 65 Allaart CF, Pooit SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditaiy protein C deficiency defect. Lancet 1993; 341: 134-138
    CrossrefPubMedGoogle Scholar
  • 66 Reitsma PH, Pooit SR, Allaait CF, Briët E, Bertina RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: Heterogeneity and founder effects. Blood 1991; 78: 890-894
    PubMedGoogle Scholar
  • 67 Miletich JP, Sherman L, Broze Jr GJ. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-996
    CrossrefPubMedGoogle Scholar
  • 68 Seligsohn U, Berger A, Abend A, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
    CrossrefPubMedGoogle Scholar
  • 69 Koeleman BP C, Reitsma PH, Allaart CF, Beitina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035
    PubMedGoogle Scholar
  • 70 Engesser L, Broekmans AW, Briët E, Brommer EJ P, Bertina RM. Hereditaiy protein S deficiency: Clinical manifestations. Ann Intern Med 1987; 106: 677-682
    CrossrefPubMedGoogle Scholar
  • 71 Mannucci PM, Tripodi A, Bertina RM. Protein S deficiency associated with “juvenile” arterial and venous thrombosis. Thromb Haemost 1986; 55: 440-440
    Article in Thieme ConnectPubMedGoogle Scholar
  • 72 Allaait CF, Aronson DC, Ruys T, Rosendaal FR, van Bockel JH, Bertina RM, Briët E. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1990; 64: 206-210
    Article in Thieme ConnectPubMedGoogle Scholar
  • 73 Reitsma PH, Ploos van Amstel HK, Bertina RM. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 1994; 93: 486-492
    CrossrefPubMedGoogle Scholar
  • 74 Gandrille S, Brogel D, Eschwege-Gufflet V, Aillurd MF, Dreyfus M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sié P, Toulon P, and Aiach M. Identification of 15 different candidate causal point mutations and 3 polymoiphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 1995; 85: 130-138
    PubMedGoogle Scholar
  • 75 Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL. A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 1991; 77: 551-559
    PubMedGoogle Scholar
  • 76 Ploos van Amstel HK, Huisman MV, Reitsma PH, ten Cate JW, Bertina RM. Partial protein S gene deletion in a family with hereditaiy thrombophilia. Blood 1989; 73: 479-483
    PubMedGoogle Scholar
  • 77 Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw PP, Van Der Linden IK, Reitsma PH. Heerlen polymoiphism of the protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-548
    PubMedGoogle Scholar
  • 78 Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-508
    PubMedGoogle Scholar
  • 79 Comp PC, Esmon CT. Recurrent thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525-1528
    CrossrefPubMedGoogle Scholar
  • 80 Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin IH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300
    PubMedGoogle Scholar
  • 81 Zöller B, Garcia de Frutos P, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isofoims in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genotype. Blood. 1994 submitted:
    PubMedGoogle Scholar
  • 82 Mannucci PM, Valsecchi C, Krashmalnicoff A, Faioni EM, Tripodi A. Familial dysfunction of protein S. Thromb Haemost 1989; 62: 763-766
    Article in Thieme ConnectPubMedGoogle Scholar
  • 83 Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 1994; 83: 683-690
    PubMedGoogle Scholar
  • 84 Faioni EM, Franchi F, Asti D, Sacchi E, Bemardi F, Mannucci PM. Resi stance to activated protein C in nine thrombophilic families: Interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067-1071
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Dahlbäck B. Thrombophilia. In: Friedmann T, Gianelli FG. eds. Advances in Genetics. Orlando,FL: Academic Press; 1995. in press
    Google Scholar
  • 86 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Nad Acad Sci USA 1994; 81: 1396-1400
    PubMedGoogle Scholar
  • 87 Sun X, Evatt B, Griffin JH. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 1994; 83: 3120-3125
    PubMedGoogle Scholar
  • 88 Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston E, Peake IR. High prevalence of a mutation in the factor V gene within the UK population: Relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-222
    CrossrefPubMedGoogle Scholar
  • 89 Baker R, Thom J, Vanbockxmeer F. Diagnosis of activated protein C resistance (factor V Leiden). Lancet 1994; 344: 1162-1162
    PubMedGoogle Scholar
  • 90 Alhenc-Gelas M, Gandrille S, Aubry ML, Emmerich J, Fiessinger JN, Aiach M. Unexplained thrombosis and factor V Leiden mutation. Lancet 1994; 344: 555-556
    PubMedGoogle Scholar
  • 91 Hellgren M, Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol. 1994 submitted:
    PubMedGoogle Scholar
  • 92 Svensson PJ, Dahlbäck B. Novel mechanism for thrombosis characterized by poor anticoagulant response to activated protein C constitutes a major cause of thrombophilia. Thromb Haemost 1993; 69: 999-999
    PubMedGoogle Scholar
  • 93 Svensson PJ, Dahlbäck B. Twenty novel families with thrombophilia and inherited resistance to activated protein C. Thromb Haemost 1993; 69: 1252 (abstract)
    PubMedGoogle Scholar
  • 94 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 1993; 82: 1989-1993
    PubMedGoogle Scholar
  • 95 Halbmayer WM, Haushofer A, Schon R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinol 1994; 5: 51-57
    CrossrefPubMedGoogle Scholar
  • 96 Lindblad B, Svensson PJ, Dahlback B. Arterial and venous thromboembolism with fatal outcome in a young man with inherited resistance to activated protein C. Lancet 1994; 343: 917-917
    CrossrefPubMedGoogle Scholar
  • 97 Holm J, Zöller B, Svensson PJ, Bemtorp E, Erhardt L, Dahlbäck B. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994; 344: 952-953
    PubMedGoogle Scholar
  • 98 Cushman M, Bhushan F, Bovill E, Tracy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994; 72: 647-647
    Article in Thieme ConnectPubMedGoogle Scholar
  • 99 Samani NJ, Lodwick D, Martin D, Kimber P. Resistance to activated protein C and risk of premature myocardial infarction. Lancet 1994; 344: 1709-1710
    PubMedGoogle Scholar
  • 100 Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
    CrossrefPubMedGoogle Scholar
  • 101 Dahlbäck B. Physiological anticoagulation. Inherited resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-927
    CrossrefPubMedGoogle Scholar
  • 102 Zöller B, Bemtsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1994 in press
    PubMedGoogle Scholar
  • 103 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral -contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
    CrossrefPubMedGoogle Scholar
  • 104 Majerus PW. Bad blood by mutation. Nature 1994; 369: 14-15
    CrossrefPubMedGoogle Scholar
  • 105 de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-886
    Article in Thieme ConnectPubMedGoogle Scholar
  • 106 Rosén S, Johansson K, Lindberg K, Dahlbäck B. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. Thromb Haemost 1994; 72: 255-260
    Article in Thieme ConnectPubMedGoogle Scholar
  • 107 Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-1163
    PubMedGoogle Scholar
  • 108 Trossaert M, Conard J, Horellou MH, Samama MM, Ireland H, Bayston TA, Lane DA. Modified APC resistance assay for patients on oral anticoagulants. Lancet 1994; 344: 1709-1709
    PubMedGoogle Scholar
  • 109 Cripe LD, Moore KD, Kane WH. Structure of the geneforhuman coagulation factor V. Biochemistry 1992; 31: 3777-3785
    CrossrefPubMedGoogle Scholar
  • 110 Bauer KA. Hypercoagulability - a new cofactor in the protein C anticoagulant pathway. N Engl J Med 1994; 330: 566-567
    CrossrefPubMedGoogle Scholar
  • 111 Dahlbäck B. Bovine coagulation factor V visualized with electron microscopy; ultra structure of the isolated activated forms and of the activation fragments. J Biol Chem 1986; 261: 9495-9501
    PubMedGoogle Scholar
  • 112 Dahlbäck B. Inherited thrombophilia. Resistance to activated protein C as a basis for venous thromboembolism. Blood 1995; 85: 607-614
    PubMedGoogle Scholar